Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Entrada Therapeutics (NASDAQ:TRDA) reported its Q4 earnings results on Wednesday, March 13, 2024 at 07:00 AM.
Here's what investors need to know about the announcement.
Entrada Therapeutics missed estimated earnings by -71.0%, reporting an EPS of $-0.29 versus an estimate of $-0.17.
Revenue was up $41.85 million from the same period last year.
Last quarter the company beat on EPS by $1.76 which was followed by a 1.0% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Entrada Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: TRDA